Tchaikapharma High Quality Medicines AD (BUL:THQM)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Production and Trade of Medicinal Forms	32.74M	27.24M	24.80M	22.06M	21.70M
Production and Trade of Medicinal Forms Growth	20.17%	9.83%	12.46%	1.65%	5.10%
Total	32.74M	27.24M	24.80M	22.06M	21.70M
Total Growth	20.17%	9.83%	12.46%	1.65%	5.10%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Bulgaria	31.76M	25.97M	24.06M	21.39M	21.40M
Bulgaria Growth	22.32%	7.95%	12.47%	-0.03%	6.94%
European Union	711.54K	821.70K	427.43K	390.02K	194.32K
European Union Growth	-13.41%	92.25%	9.59%	100.71%	-23.66%
Exports	214.84K	375.74K	285.29K	247.92K	94.09K
Exports Growth	-42.82%	31.70%	15.07%	163.48%	-54.10%
Total	32.69M	27.17M	24.77M	22.03M	21.68M
Total Growth	20.33%	9.68%	12.45%	1.58%	5.95%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 7, 2026

Data Sources Report a data error